17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydroxyprogesterone caproate.
Acarbose
Acarbose may increase the hypoglycemic activities of Insulin Detemir.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Insulin Detemir.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.
Alogliptin
Alogliptin may increase the hypoglycemic activities of Insulin Detemir.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Insulin Detemir.
Advertisement
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Insulin Detemir.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Insulin Detemir.
Anhydrous Tacrolimus
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Tacrolimus.
Advertisement
Aripiprazole
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.
Atazanavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Atazanavir.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Insulin Detemir.
Bendroflumethiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Betamethasone.
Brexpiprazole
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Bumetanide.
Buserelin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Buserelin.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Insulin Detemir.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Insulin Detemir.
Ceritinib
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Chlorpropamide may increase the hypoglycemic activities of Insulin Detemir.
Chlorthalidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Chlorthalidone.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Insulin Detemir.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Insulin Detemir.
Citalopram
Citalopram may increase the hypoglycemic activities of Insulin Detemir.
Clozapine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Insulin Detemir can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Darunavir.
Desogestrel
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Insulin Detemir.
Dexamethasone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Diazoxide.
Dienogest
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Insulin Detemir.
Disopyramide
Disopyramide may increase the hypoglycemic activities of Insulin Detemir.
Drospirenone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Drospirenone.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Insulin Detemir.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Insulin Detemir.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Insulin Detemir.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Insulin Detemir.
Epinephrine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Epinephrine.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Insulin Detemir.
Estradiol
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Etacrynic acid.
Ethinyl Estradiol
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Everolimus.
Exenatide
Exenatide may increase the hypoglycemic activities of Insulin Detemir.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Insulin Detemir.
Fludrocortisone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Fludrocortisone.
Flumequine
Flumequine may increase the hypoglycemic activities of Insulin Detemir.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Insulin Detemir.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Insulin Detemir.
Fluvoxamine
Fluvoxamine may increase the hypoglycemic activities of Insulin Detemir.
Fosamprenavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Fosamprenavir.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Insulin Detemir.
Furosemide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Insulin Detemir.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Insulin Detemir.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Insulin Detemir.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Insulin Detemir.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Insulin Detemir.
Gliclazide
Gliclazide may increase the hypoglycemic activities of Insulin Detemir.
Glimepiride
Glimepiride may increase the hypoglycemic activities of Insulin Detemir.
Glipizide
Glipizide may increase the hypoglycemic activities of Insulin Detemir.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Insulin Detemir.
Glyburide
Glyburide may increase the hypoglycemic activities of Insulin Detemir.
Goserelin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Insulin Detemir.
Histrelin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Indinavir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Insulin Detemir.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Insulin Detemir.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Insulin Detemir.
Insulin, Aspart Protamine, Human
Insulin Aspart may increase the hypoglycemic activities of Insulin Detemir.
Insulin, Aspart, Human
Insulin Aspart may increase the hypoglycemic activities of Insulin Detemir.
Insulin, Glulisine, Human
Insulin Detemir may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Insulin Detemir.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Insulin Detemir.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Insulin Detemir.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Insulin Detemir.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Insulin Detemir.
Lanreotide
Insulin Detemir may increase the hypoglycemic activities of Lanreotide.
Leuprolide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Leuprolide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Insulin Detemir.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Insulin Detemir.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Insulin Detemir.
Levonorgestrel
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Levonorgestrel.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Insulin Detemir.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Insulin Detemir.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Insulin Detemir.
Lopinavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Lurasidone.
Mecasermin
Mecasermin may increase the hypoglycemic activities of Insulin Detemir.
Mecasermin Rinfabate
Mecasermin may increase the hypoglycemic activities of Insulin Detemir.
Medrogestone
The serum concentration of Insulin Detemir can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Insulin Detemir.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Insulin Detemir.
Mestranol
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Mestranol.
Metformin
Metformin may increase the hypoglycemic activities of Insulin Detemir.
Methotrimeprazine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Insulin Detemir.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Insulin Detemir.
Methylprednisolone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Insulin Detemir.
Metolazone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Metolazone.
Mifepristone
Mifepristone may increase the hypoglycemic activities of Insulin Detemir.
Miglitol
Miglitol may increase the hypoglycemic activities of Insulin Detemir.
Miglustat
Miglustat may increase the hypoglycemic activities of Insulin Detemir.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Insulin Detemir.
Minaprine
Minaprine may increase the hypoglycemic activities of Insulin Detemir.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Insulin Detemir.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Insulin Detemir.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Insulin Detemir.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Insulin Detemir.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Insulin Detemir.
Nateglinide
Nateglinide may increase the hypoglycemic activities of Insulin Detemir.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Insulin Detemir.
Nelfinavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Insulin Detemir.
Nilotinib
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Insulin Detemir.
Norgestimate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Norgestimate.
Octreotide
Octreotide may increase the hypoglycemic activities of Insulin Detemir.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Insulin Detemir.
Olanzapine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Insulin Detemir.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Insulin Detemir.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Insulin Detemir.
Paliperidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Insulin Detemir.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Insulin Detemir.
Pasireotide
Insulin Detemir may increase the hypoglycemic activities of Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Insulin Detemir.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Insulin Detemir.
Pentamidine
Pentamidine may increase the hypoglycemic activities of Insulin Detemir.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Insulin Detemir.
Phenformin
Phenformin may increase the hypoglycemic activities of Insulin Detemir.
Pioglitazone
Pioglitazone may increase the hypoglycemic activities of Insulin Detemir.
Piperazine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Polythiazide.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Insulin Detemir.
Prednisolone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Detemir.
Procaine
Procaine may increase the hypoglycemic activities of Insulin Detemir.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Insulin Detemir.
Progesterone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Progesterone.
Quetiapine
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Quinethazone.
Quinine
Quinine may increase the hypoglycemic activities of Insulin Detemir.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Insulin Detemir.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Insulin Detemir.
Repaglinide
Repaglinide may increase the hypoglycemic activities of Insulin Detemir.
Risperidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Ritonavir.
Rosiglitazone
Rosiglitazone may increase the hypoglycemic activities of Insulin Detemir.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Insulin Detemir.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Insulin Detemir.
Saquinavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Saquinavir.
Saxagliptin
Saxagliptin may increase the hypoglycemic activities of Insulin Detemir.
Saxagliptin Anhydrous
Saxagliptin may increase the hypoglycemic activities of Insulin Detemir.
Selegiline
Selegiline may increase the hypoglycemic activities of Insulin Detemir.
Sertraline
Sertraline may increase the hypoglycemic activities of Insulin Detemir.
Sirolimus
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Sirolimus.
Sitagliptin
Sitagliptin may increase the hypoglycemic activities of Insulin Detemir.
Sitagliptin Phosphate
Sitagliptin may increase the hypoglycemic activities of Insulin Detemir.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Insulin Detemir.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Insulin Detemir.
Sulfadiazine
Sulfadiazine may increase the hypoglycemic activities of Insulin Detemir.
Sulfamethoxazole
Sulfamethoxazole may increase the hypoglycemic activities of Insulin Detemir.
Sulfisoxazole
Sulfisoxazole may increase the hypoglycemic activities of Insulin Detemir.
Sunitinib
Sunitinib may increase the hypoglycemic activities of Insulin Detemir.
Tacrolimus
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Tacrolimus.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Insulin Detemir.
Temsirolimus
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Insulin Detemir.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Insulin Detemir.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Insulin Detemir.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Insulin Detemir.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Insulin Detemir.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Insulin Detemir.
Tipranavir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Tipranavir.
Tolazamide
Tolazamide may increase the hypoglycemic activities of Insulin Detemir.
Tolbutamide
Tolbutamide may increase the hypoglycemic activities of Insulin Detemir.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Insulin Detemir.
Torsemide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Insulin Detemir.
Triamcinolone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Trichlormethiazide.
Triptorelin
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Triptorelin.
Troglitazone
Troglitazone may increase the hypoglycemic activities of Insulin Detemir.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Insulin Detemir.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Insulin Detemir.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Insulin Detemir.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Insulin Detemir.
Vorinostat
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Vorinostat.
Ziprasidone
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Ziprasidone.
